Xiaojie Zhang, MD, and Akshat Singhal, PhD, discuss their research leveraging deep learning to predict how patients with ER+/HER2- breast cancer will respond to palbociclib.
Akshat Singhal, PhD
Akshat Singhal, PhD, is a postdoctoral scholar at UC San Diego.
Articles by Akshat Singhal, PhD